Biogen, Inc. (BIIB)
218.50
-3.00
(-1.35%)
USD |
NASDAQ |
Aug 28, 16:00
218.18
-0.32
(-0.15%)
After-Hours: 20:00
Biogen Cash and Short Term Investments (Quarterly) : 1.285B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.285B |
| March 31, 2026 | 4.283B |
| December 31, 2025 | 3.816B |
| September 30, 2025 | 3.960B |
| June 30, 2025 | 2.759B |
| March 31, 2025 | 2.598B |
| December 31, 2024 | 2.375B |
| September 30, 2024 | 1.699B |
| June 30, 2024 | 1.909B |
| March 31, 2024 | 1.074B |
| December 31, 2023 | 1.050B |
| September 30, 2023 | 2.288B |
| June 30, 2023 | 6.078B |
| March 31, 2023 | 5.041B |
| December 31, 2022 | 4.893B |
| September 30, 2022 | 4.911B |
| June 30, 2022 | 4.798B |
| March 31, 2022 | 3.752B |
| December 31, 2021 | 3.802B |
| September 30, 2021 | 2.955B |
| June 30, 2021 | 3.051B |
| March 31, 2021 | 2.538B |
| December 31, 2020 | 2.610B |
| September 30, 2020 | 3.580B |
| June 30, 2020 | 4.328B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.860B |
| December 31, 2019 | 4.476B |
| September 30, 2019 | 4.437B |
| June 30, 2019 | 2.952B |
| March 31, 2019 | 3.909B |
| December 31, 2018 | 3.538B |
| September 30, 2018 | 4.428B |
| June 30, 2018 | 3.224B |
| March 31, 2018 | 5.916B |
| December 31, 2017 | 3.689B |
| September 30, 2017 | 3.508B |
| June 30, 2017 | 2.893B |
| March 31, 2017 | 2.880B |
| December 31, 2016 | 4.895B |
| September 30, 2016 | 4.316B |
| June 30, 2016 | 3.797B |
| March 31, 2016 | 3.585B |
| December 31, 2015 | 3.428B |
| September 30, 2015 | 5.843B |
| June 30, 2015 | 2.369B |
| March 31, 2015 | 2.152B |
| December 31, 2014 | 1.845B |
| September 30, 2014 | 1.861B |
| June 30, 2014 | 1.573B |
| March 31, 2014 | 1.260B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.055B |
| AbbVie, Inc. | 6.569B |
| Regeneron Pharmaceuticals, Inc. | 8.005B |
| Vertex Pharmaceuticals, Inc. | 7.863B |
| Amgen, Inc. | 13.99B |